Unlock transformative cancer insights
Oxford Nanopore sequencing offers a unique multiomic solution for cancer research and precision oncology. With real-time analysis of native DNA and RNA fragments of any length, capture previously hidden variants and modifications in a single consolidated assay.
Why choose Oxford Nanopore?
Comprehensive multiomic insights to unlock more cancer biology
Simple end-to-end workflows for streamlined bioinformatic analysis
Direct RNA nanopore sequencing for the most complete view of the cancer transcriptome
It’s a real joy to use adaptive sampling. It’s a very cost-effective and efficient process. We’ve used it across many projects.Tom Walsh
University of Washington
PromethION range
PromethION Flow Cells offer the highest output for nanopore sequencing, achieving enhanced coverage of cancer genomes and high-resolution analysis of full-length transcripts. The PromethION range of devices is ideal for comprehensive whole-genome characterisation and biomarker discovery across any number of cancer samples.
Accelerating cancer research through comprehensive genomic analysis
In this white paper, discover how Oxford Nanopore sequencing technology provides extensive analyses of structural variants, repeat regions, methylation, cell-free and circulating tumour DNA (cfDNA and ctDNA), fusion genes — in one go — to truly understand cancer biology.
